Results 181-200 of 4,359 for speaker:Gino Kenny
- Joint Oireachtas Committee on Health: National Children’s Hospital: Discussion (9 Oct 2024)
Gino Kenny: Yes, grand.
- Joint Oireachtas Committee on Health: National Children’s Hospital: Discussion (9 Oct 2024)
Gino Kenny: I know that.
- Joint Oireachtas Committee on Health: National Children’s Hospital: Discussion (9 Oct 2024)
Gino Kenny: I second that.
- Joint Oireachtas Committee on Health: National Children’s Hospital: Discussion (9 Oct 2024)
Gino Kenny: No.
- Joint Oireachtas Committee on Health: National Children’s Hospital: Discussion (9 Oct 2024)
Gino Kenny: Did Royal BAM give any commitment about the contribution from its side to the extra costs of this project from where it was initially a number of years ago to where it is now? The people who have to pay it are the taxpayers of this country.
- Joint Oireachtas Committee on Health: National Children’s Hospital: Discussion (9 Oct 2024)
Gino Kenny: Why is that?
- Written Answers — Department of Health: Medicinal Products (8 Oct 2024)
Gino Kenny: 519. To ask the Minister for Health when a decision will be made by the HSE on the reimbursement of fenfluramine (fintepla) for the treatment of refractory epilepsy (details supplied); and if he will make a statement on the matter. [39728/24]
- Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (3 Oct 2024)
Gino Kenny: We have received apologies from Deputy Jennifer Murnane O'Connor. Parliamentary privilege is considered to apply to the utterances of members participating online in a committee meeting when their participation is from within the parliamentary precincts. There can be no assurances with regard to participation online from outside the parliamentary precincts, and members should be mindful...
- Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (3 Oct 2024)
Gino Kenny: I thank Dr. Healy. To conclude, I invite Dr. Barry Cullen.
- Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (3 Oct 2024)
Gino Kenny: Thank you, Dr. Cullen. Now it is over to committee members. The first contributor is Senator Seery Kearney.
- Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (3 Oct 2024)
Gino Kenny: Deputy Wynne wants to come in at the end. Is that correct?
- Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (3 Oct 2024)
Gino Kenny: I thank Dr. Healy. Our next speaker is Deputy Wynne.
- Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (3 Oct 2024)
Gino Kenny: There were a lot of questions. Who wants to take them on in a limited amount of time?
- Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (3 Oct 2024)
Gino Kenny: Does Mr. Mullins wish to come in briefly?
- Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (3 Oct 2024)
Gino Kenny: Mr. Broderick, briefly.
- Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (3 Oct 2024)
Gino Kenny: Now we are onto additional questions. Deputies Gould and Ward have indicated.
- Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (3 Oct 2024)
Gino Kenny: I call Deputy Ward. In the meantime, could Deputy Gould take the Chair for a few minutes?
- Committee on Drugs Use: A Health-Led Approach: Discussion (Resumed) (3 Oct 2024)
Gino Kenny: I just have one question. This has been a really informative conversation thus far. Mr. Paul Reid said after the assembly's publication that this was an historic opportunity to address the wrongs of the past 50 years around drug policy. I do not want to misquote him but Mr. Mullins spoke about the limitations of decriminalisation. I agree there are limitations to decriminalisation,...